arrow
H

Herlander Marques

universidade de coimbra
H指数:16
被引数:1,085

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sociodemographic, Clinical, and Therapeutic Characterization of Multiple Myeloma Patients (CharisMMa Study) with Symptomatic Relapse and/or Refractory Disease: An Observational, Multicenter Study in Portugal

CharisMMa研究:葡萄牙多发性骨髓瘤患者的社会人口统计学、临床和治疗效果特征(伴有症状性复发和/或难治性疾病):一项观察性、多中心研究

2026-05-190
PRE
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
LEUKEMIA
IF13.4
2023-09-182
OAAI
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
2022-10-010
OA
A polygenic risk score for multiple myeloma risk prediction
2021-11-306
OAAI
Genetically determined telomere length and multiple myeloma risk and outcome
2021-04-1412
OAAI
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
2021-03-305
OAAI
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
2020-11-203
OAAI
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
LANCET
IF88.5
2019-01-01190
OAAI
Identification of miRSNPs associated with the risk of multiple myeloma

与多发性骨髓瘤风险相关的miRSNPs的鉴定

2016-11-098
OAAI
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients (vol 6, 7539, 2015)
2015-12-092
OAAI
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium
2015-08-0111
OAAI
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

全基因组关联研究鉴定与多发性骨髓瘤患者生存相关的16p13变异

2015-07-2235
OAAI